ABOUT THIS EPISODE
Ready to move your Generative AI initiatives from experimentation to execution? Join Jim Keller, AWS Global CEO, Quantiphi and Rima Olinger (WW Director, Data & AI GTM – Amazon Quick at AWS) as they discuss how enterprises are accelerating AI adoption with Amazon Quick. Learn how the Quantiphi–AWS partnership is helping organizations boost productivity, overcome adoption barriers, and launch production-ready AI use cases in as little as 45 days on Amazon Quick through the "Live in 45" initiative.
Visit www.quantiphi.com for more information.
Hosted on Acast. See acast.com/privacy for more information.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
Are you drowning in paperwork or focusing on patient care?
In this episode of Phi Moments, Farah Ismail, Senior Vice President, Chief Legal, Privacy and Compliance Officer at SE Health, in conversation with our host, Kanishk Mehta, Product Leader – baioniq at Quantiphi, move past the GenAI hype to …
Join us for the second episode of the Phi Moments podcast, "Building Next-Gen Platforms for Preclinical Testing," where host Rahul Ramchandra Ganar, Head - Life Sciences, Quantiphi dives into the innovations redefining drug discovery and development. We're joined by exceptional leaders, including A…
Stuck in pilot purgatory with your AI initiatives? It’s time to build a repeatable AI engine. In this episode, we explore the incredible AI transformation journey of biotechnology innovator, Insmed, and how their strategic partnership with Quantiphi is bringing their vision to life.
Join our host B…
Are you measuring engineering success by lines of code — or by the outcomes those lines create?
In this episode of Phi Moments, we move beyond the GenAI hype to explore what real-world adoption actually looks like: measurable ROI, practical implementation, and the Phi Moments that emerge when legac…
What if you could rethink preclinical testing — beyond animal models, beyond limitations? Join us for the first episode of our podcast, "Rethinking Preclinical Testing – The DART Advantage," featuring Dr. Subhadra Dravida, Founder & CEO, Transcell Biologics, as the guest speaker, in a powerful …
Disclaimer: The podcast and artwork embedded on this page are from Quantiphi, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
